Jazz Pharmaceuticals, Boehringer Ingelheim neurology news

A District Court Judge issued an opinion in a Markman hearing that agreed with Jazz's interpretation of the majority of disputed claims in eight patents covering the company's narcolepsy drug Xyrem s...